Abstract:Background: Incidental findings (IFs) are common on low dose CT obtained during lung cancer screening (LCS). The identification and management of clinically significant …
Abstract: Objective: Tobacco dependence treatment (TDT) should be offered to all lung cancer screening (LCS) participants who smoke. We sought to examine the provision of TDT among …
Abstract: Background: Black Americans, including military veterans, experience worse health outcomes. In the United States, Black men have the highest lung cancer mortality and are …
Abstract: Introduction: The 2021 update to the United States Preventive Services Task Force guidelines for lung cancer screening (LCS) aims to reduce disparities derived from sex, …
Abstract: INTRODUCTION: Lung cancer screening is underutilized, especially in rural areas where lung cancer mortality is high. Approximately 11.2% of the U.S. population over age …
Abstract: In 2013, the US Preventive Services Task Force recommended lung cancer screening (LCS) using low-dose computed tomography (LDCT) for high-risk populations. The Veterans …
Abstract: Precision medicine is responsible for improvements in outcomes and treatment for non-small cell lung cancer (NSCLC), replacing empiric cytotoxic agents with …
Abstract: Improving access to and promoting the uptake of lung cancer screening (LCS) remains a priority within the Veterans Health Administration (VHA) due to its potential to …
Abstract: Background: Despite randomized trials demonstrating a mortality benefit to low-dose computed tomography screening to detect lung cancer, uptake of lung cancer screening …
Abstract: BACKGROUND: Shared Decision-Making to discuss how the benefits and harms of lung cancer screening align with patient values is required by the US Centers for Medicare and …